2091-51-2

Usage

InChI:InChI=1/C15H23BrO/c1-14(2,3)11-7-10(9-16)8-12(13(11)17)15(4,5)6/h7-8,17H,9H2,1-6H3

Upstream product

• 1669-36-9 4-bromo-4-methyl-2,6-di-tert-butylcyclohexa-2,5-dienone 
• 71-43-2 benzene 
• 128-37-0 2,6-di-tert-butyl-4-methyl-phenol 
• 506-96-7 Acetyl bromide 
• 88-27-7 N,N-dimethyl-(3,5-di-tert-butyl-4-hydroxybenzyl)amine 
• 88-26-6 3,5-di-tert-butyl-4-hydroxybenzyl alcohol 
• 1620-98-0 3,5-di-t-butyl-4-hydroxybenzaldehyde 

Downstream Products

• 87-97-8 2,6-di-tert-butyl-4-methoxymethylene-phenol 
• 1516-94-5 1,2-bis(3,5-di-tert-butyl-4-hydroxyphenyl)ethane 
• 88-26-6 3,5-di-tert-butyl-4-hydroxybenzyl alcohol 
• 809-73-4 3,3',5,5'-tetra-tert-butyl-4,4'-stilbenequinone 
• 5530-31-4 2,6-di-tert-butyl-4-(3-butenyl)phenol 
• 1611-07-0 3,5-Di-tert-butyl-4-hydroxyphenylacetonitrile 
• 2607-52-5 2,6-di-tert-butyl-4-methylene-2,5-cyclohexadien-1-one 
• 78536-43-3 <3,5-di(tert-butyl)>-4-hydroxybenzylthiocyanate 
• 15367-50-7 S-3,5-di(tert-butyl)-4-hydroxybenzyl-O-ethylxanthate 
• 17258-83-2 N,N-di-ethyl-dithiocarbamic acid 3,5-di-tert-butyl-4-hydroxy-benzyl ester 
• 6029-97-6 2-[(3,5-di(tert-butyl)-4-hydroxybenzyl)sulfanyl]benzothiazole 
• 980-17-6 diisopropyl (3,5-di-tert-butyl-4-hydroxybenzyl)phosphonate 
• 167849-33-4 3',5'-di-tert-butyltyrosine ethyl ester 
• 500695-43-2 3',5'-di-tert-butyltyrosine benzyl ester 

Relevant academic research and scientific papers

With anti-oxidation function of the second carbide imine compound and its preparation method

The invention will be hindered phenol antioxidant structure and connected with the carbodiimide structure, by substitution, the coupling reaction for synthesis of molecular weight, higher melting point single carbodiimide high carbonization two imine comp

MULTIFUNCTIONAL SYNERGISTIC MACROMOLECULAR ANTI-OXIDATION STABILIZER AND PREPARATION METHOD AND USE THEREOF

Disclosed is an anti-oxidation stabilizer, which has the following structure (A), wherein R1 is a connection chain, and the connection chain is a fatty chain, an aromatic structural chain or a fatty and aromatic structurally combined chain; R2 is (B), and X is O, S, N or NH or —CONR—, Z is O, S, N or NH, and X is different from Z; R is a fatty chain, an aromatic group, a sterically hindered amine or sterically hindered phenol, R3 is a fatty chain, an aromatic group, a sterically hindered amine or sterically hindered phenol, and R is identical to R3, or R is different from R3; n is a positive integer including 1, n1 is a positive integer including 1, and n is identical to n1, or n is different from n1.

Synthesis and antimicrobial activities of phosphonium salts on basis of triphenylphosphine and 3,5-di-tert-butyl-4-hydroxybenzyl bromide

We report the structures of two new phosphonium salts prepared via the reaction of (substituted)benzyl bromides with triphenylphosphine. The antibacterial and antifungal activities are reported.

Synthesis and crystal structure analysis of substituted diethyl malonate

Abstract As intermediates of light stabilizer malonate, diethyl 3,5-di-t-butyl-4-hydroxybenzyl phenyl malonates (F.W. 454.58) was synthesized, characterized by 1H NMR, element analysis and confirmed by X-ray crystal structure analysis. This compound cryst

NANOPARTICLE INCLUDING MULTI-FUNCTIONAL LIGAND AND METHOD

A nanoparticle including an inorganic core comprising at least one metal and/or at least one semi-conductor compound comprising at least one metal includes a coating or shell disposed over at least a portion of a surface of the core. The coating can inclu

Synthesis and antioxidant activities of 3,5-dialkoxy-4-hydroxycinnamamides

A series of 3,5-dialkoxy-4-hydroxycinnamamides 6 and 7 was synthesized, and their antioxidant activity was assessed using the thiobarbituric acid reactive substance (TBARS) assay. Interestingly, cinnamamides with longer alkoxy groups on the C-3 and C-5 positions display enhanced inhibition, and most of the compounds in the series tested exhibit excellent lipid peroxidation inhibitory activities. Some cinamamides bearing hexyloxy or 2,6-di-tert-butyl-4-methyl phenol groups have submicromolar inhibitory activities.

Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them

The invention relates to new derivatives of 2-(iminomethyl)amino-phenyl which are NO synthase inhibitors and can trap reactive oxygen species. These compounds can notably be used for the treatment of stroke, of neurodegenerative diseases and of ischemic or hemorragic cardiac or cerebral infarctions. These compounds include: N-{4-[({[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}amino)methyl]phenyl}thiophene-2-carboximidamide; N-{3-[({[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}amino)methyl]phenyl}thiophene-2-carboximidamide; N-(4-{[{[4-(3,5-di-tert-butyl-4-hydroxyphenyl)-1,3-thiazol-2-yl]methyl}(methyl)amino]methyl}phenyl)thiophene-2-carboximidamide; N-[3-({[3-(3,5-di-tert-butyl-4-hydroxyphenyl)propyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-(3-{[(3,5-di-tert-butyl-4-hydroxybenzyl)amino]methyl}phenyl)thiophene-2-carboximidamide; N-[3-({[2-(3,5-di-tert-butyl-4-hydroxyphenyl)ethyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-[3-({[3-(4-hydroxy-3,5-diisopropylphenyl)propyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-(3-{[(4-hydroxy-3,5-diisopropylbenzyl)amino]methyl}phenyl) thiophene-2-carboximidamide; N-[3-({[2-(4-hydroxy-3,5-diisopropylphenyl)ethyl]amino}methyl)phenyl]thiophene-2-carboximidamide; N-2-(3,5-di-tert-butyl-4-hydroxybenzoyl)-N-1-(4-{[imino(thien-2-yl)methyl]amino}phenyl)-L-leucinamide; and pharmaceutically acceptable salts thereof.

Antiozonant cum antioxidant, process for preparation

The present invention relates to a novel antiozonant as well as antioxidant based on functionalized hindered phenol and the process for the preparation thereof of formula 1 wherein R1is tert-butyl and R2and R3are C1/

Diol-functionalized antioxidant and process for preparation thereof

Diol-functionalized antioxidants and the process for the preparation thereof are disclosed and have the general formula (I): wherein: R1 is tert-butyl and R2 is C1 to C8 linear or branched alkyl. The invention a